Ionis Pharmaceuticals
Price & Volume
Stats
See moreOpen | $28.44 |
Previous Close | $28.35 |
Day Range | $28.08-$28.71 |
52W Range | $23.95-$52.34 |
Market Cap | $4.5B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $705.1M |
Revenue Growth (YoY) | -30.2% |
Gross Profit (12 Mos) | -$207.6M |
Diluted EPS | -$3.04 |
News
See moreYahoo Finance • 24 days ago
Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting
Yahoo Finance • last month
Ionis and Ono announce global license agreement for sapablursen in polycythemia vera
Yahoo Finance • 2 months ago
New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control
Yahoo Finance • 3 months ago
FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA
About
CEO | Dr. Brett P. Monia Ph.D. |
CFO | Ms. Elizabeth L. Hougen M.A., M.B.A., M.S. |
Address | 2855 Gazelle Court, Carlsbad, CA, United States, 92010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,069 |
